Boehringer Ingelheim planning two new Global Clinical Trials for Pradaxa ® (dabigatran etexilate) in expanded patient populations

Boehringer Ingelheim planning two new Global Clinical Trials for Pradaxa ® (dabigatran etexilate) in expanded patient populations
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news